Wu‐Tao Zeng

812 total citations
18 papers, 590 citations indexed

About

Wu‐Tao Zeng is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Wu‐Tao Zeng has authored 18 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Wu‐Tao Zeng's work include Renin-Angiotensin System Studies (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Cardiac Arrhythmias and Treatments (2 papers). Wu‐Tao Zeng is often cited by papers focused on Renin-Angiotensin System Studies (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Cardiac Arrhythmias and Treatments (2 papers). Wu‐Tao Zeng collaborates with scholars based in China. Wu‐Tao Zeng's co-authors include Yun‐Jiu Cheng, Yugang Dong, Su‐Hua Wu, Fengjuan Yao, Dongdan Zheng, Zhihao Liu, Kai Tang, Hong Ma, Weiyan Chen and Wei‐Yi Mei and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and Biochemical and Biophysical Research Communications.

In The Last Decade

Wu‐Tao Zeng

18 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wu‐Tao Zeng China	11	310	140	91	87	82	18	590
S. Mueller Germany	14	466 1.5×	144 1.0×	132 1.5×	74 0.9×	78 1.0×	49	936
Argyri Gialeraki Greece	18	246 0.8×	108 0.8×	76 0.8×	96 1.1×	65 0.8×	41	789
Carmen Fernández‐Capitán Spain	17	240 0.8×	336 2.4×	99 1.1×	32 0.4×	99 1.2×	47	749
Khagendra Dahal United States	15	434 1.4×	133 0.9×	78 0.9×	93 1.1×	38 0.5×	57	779
Richard C. Becker United States	15	449 1.4×	160 1.1×	66 0.7×	51 0.6×	55 0.7×	35	681
Steven R. Kayser United States	13	220 0.7×	63 0.5×	73 0.8×	47 0.5×	52 0.6×	26	776
Janice D. Nunnelee United States	10	272 0.9×	224 1.6×	57 0.6×	309 3.6×	82 1.0×	43	780
Alan Yean Yip Fong Malaysia	15	350 1.1×	35 0.3×	63 0.7×	60 0.7×	131 1.6×	78	659
James W. Hainer United States	15	429 1.4×	148 1.1×	24 0.3×	142 1.6×	62 0.8×	23	722
Simon Kouz Canada	13	436 1.4×	63 0.5×	59 0.6×	61 0.7×	76 0.9×	34	710

Countries citing papers authored by Wu‐Tao Zeng

Since Specialization

Citations

This map shows the geographic impact of Wu‐Tao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu‐Tao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu‐Tao Zeng more than expected).

Fields of papers citing papers by Wu‐Tao Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu‐Tao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu‐Tao Zeng. The network helps show where Wu‐Tao Zeng may publish in the future.

Co-authorship network of co-authors of Wu‐Tao Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Wu‐Tao Zeng. A scholar is included among the top collaborators of Wu‐Tao Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu‐Tao Zeng. Wu‐Tao Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Shi, Hui, Meiling Liang, Weiyan Chen, et al.. (2017). Human induced pluripotent stem cell‑derived mesenchymal stem cells alleviate atherosclerosis by modulating inflammatory responses. Molecular Medicine Reports. 17(1). 1461–1468. 18 indexed citations

Yang, Yiying, Xiuting Sun, Weiyan Chen, et al.. (2017). Protective effect of angiotensin-(1-7) against hyperglycaemia-induced injury in H9c2 cardiomyoblast cells via the PI3KAkt signaling pathway. International Journal of Molecular Medicine. 41(3). 1283–1292. 8 indexed citations

Zeng, Wu‐Tao, Qing Xu, Weiyan Chen, et al.. (2016). Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese. European Journal of Clinical Pharmacology. 72(11). 1327–1334. 10 indexed citations

Zeng, Wu‐Tao, et al.. (2016). Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation. Medicine. 95(12). e2949–e2949. 17 indexed citations

Luo, Shengyuan, et al.. (2016). Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy: A Systematic Review and Meta‐analysis of 19 Studies. Journal of the American Heart Association. 5(5). 32 indexed citations

Cheng, Yun‐Jiu, Xumiao Chen, Xiao‐Xiong Lin, et al.. (2015). The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk. Journal of the American College of Cardiology. 66(20). 2173–2184. 115 indexed citations

Zeng, Wu‐Tao, Xiuting Sun, Kai Tang, et al.. (2014). Risk of Thromboembolic Events in Atrial Fibrillation With Chronic Kidney Disease. Stroke. 46(1). 157–163. 48 indexed citations

Cheng, Yun‐Jiu, Jing Zhang, Weijie Li, et al.. (2014). More Favorable Response to Cardiac Resynchronization Therapy in Women Than in Men. Circulation Arrhythmia and Electrophysiology. 7(5). 807–815. 57 indexed citations

Cheng, Yun‐Jiu, Zhihao Liu, Fengjuan Yao, et al.. (2013). Current and Former Smoking and Risk for Venous Thromboembolism: A Systematic Review and Meta-Analysis. PLoS Medicine. 10(9). e1001515–e1001515. 144 indexed citations

10.

Zeng, Wu‐Tao, Weiyan Chen, Lilong Tang, et al.. (2010). Impairment of Cardiac Function and Remodeling Induced by Myocardial Infarction in Rats are Attenuated by the Nonpeptide Angiotensin‐(1–7) Analog AVE 0991. Cardiovascular Therapeutics. 30(3). 152–161. 21 indexed citations

11.

Zeng, Wu‐Tao, Min Huang, Xiao Chen, et al.. (2010). CYP4F2rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement. British Journal of Clinical Pharmacology. 70(2). 234–240. 59 indexed citations

12.

Zeng, Wu‐Tao, et al.. (2010). [Angiotensin-(1-7) reduced postangioplasty vascular fibrosis in abdominal aorta of rabbits].. PubMed. 38(6). 531–8. 1 indexed citations

13.

Zeng, Wu‐Tao, et al.. (2009). Chronic angiotensin-(1–7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-β/Smad signaling pathway in rabbits. Biochemical and Biophysical Research Communications. 389(1). 138–144. 38 indexed citations

14.

Ma, Hong, Xinxue Liao, Xuesong Hu, et al.. (2006). [Study on up-regulation of the expression of angiotensin-converting enzyme-2 in human umbilical vein endothelial cells by telmisartan].. PubMed. 18(4). 224–8. 1 indexed citations

15.

Wang, Lichun, Hong Ma, Jiangui He, et al.. (2005). Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.. PubMed. 118(9). 731–7. 3 indexed citations

16.

Wang, Lijun, Jiangui He, Hong Ma, et al.. (2005). Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.. PubMed. 25(5). 481–7. 16 indexed citations

17.

Wang, Lijun, Hong Ma, Jiangui He, et al.. (2005). [Angiotensin-(1-7) modulates fibrinolytic imbalance induced by oxidized low-density lipoprotein in cultured human umbilical vein endothelial cells].. PubMed. 25(6). 633–7. 1 indexed citations

18.

Wang, Lichun, Hong Ma, Jiangui He, et al.. (2005). [Effects of ACE inhibitor on the calcium transient and calcium handling proteins in ventricular myocytes from rats with heart failure].. PubMed. 33(6). 513–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact